Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Sandro, Feriozzi"'
Autor:
Ursula Kirchmayer, Claudia Marino, Sandro Feriozzi, Carlo Massimetti, Micol Manzuoli, Laura Angelici, Anna Maria Bargagli, Silvia Cascini, Antonio Addis, Marina Davoli, Nera Agabiti
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Entering dialysis is a critical moment in patients’ healthcare journey, and little is known about drug therapy around it. A study funded by the Italian Medicines Agency offered the opportunity to leverage data from the Lazio Reg
Externí odkaz:
https://doaj.org/article/0ac11cda404c48319bfa157a47abc56e
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
The pathophysiology of Fabry nephropathy (FN) is induced by galactosidase A deficiency with a chronic exposure of glycolipids to every lineage of renal cells. Tissue damage is attributed to the activation of molecular pathways, resulting in tissue fi
Externí odkaz:
https://doaj.org/article/a223763f63804eaab77d568774926b2d
Autor:
Derralynn A. Hughes, Patrício Aguiar, Olivier Lidove, Kathleen Nicholls, Albina Nowak, Mark Thomas, Roser Torra, Bojan Vujkovac, Michael L. West, Sandro Feriozzi
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-15 (2022)
Abstract Background Variable disease progression confounds accurate prognosis in Fabry disease. Evidence supports the long-term benefit of early intervention with disease-specific therapy, but current guidelines recommend treatment initiation based o
Externí odkaz:
https://doaj.org/article/66f3ce4b9015408285a03a7d52421b7d
Autor:
Francesco Consolato, Maurizio De Fusco, Céline Schaeffer, Federico Pieruzzi, Francesco Scolari, Maurizio Gallieni, Chiara Lanzani, Sandro Feriozzi, Luca Rampoldi
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 33, Iss , Pp 100926- (2022)
Anderson-Fabry Disease (FD) is an X-linked lysosomal disorder caused by mutations in GLA, the gene encoding the lysosomal hydrolase α-galactosidase A (α-Gal A), leading to accumulation of glycosphingolipids in the lysosomes. FD is a multisystemic d
Externí odkaz:
https://doaj.org/article/9aaea011d5e846f6b1bd99cfbbe96960
Autor:
Cristina Chimenti, Patrizia Nencini, Federico Pieruzzi, Sandro Feriozzi, Renzo Mignani, Maurizio Pieroni, Antonio Pisani, on behalf of the GALA Working Group
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background Oral migalastat has recently been approved for the treatment of Anderson-Fabry disease (FD) in patients aged ≥16 years with amenable mutations on the basis of two phase III trials, FACETS and ATTRACT. However, with the introduct
Externí odkaz:
https://doaj.org/article/0c09aa70e85e427aa81de344d5c9610b
Publikováno v:
Journal of Nephropathology, Vol 9, Iss 4, Pp e33-e33 (2020)
Externí odkaz:
https://doaj.org/article/66570e14c168467ca62ecfdfbce68e9c
Autor:
James C Moon, Albina Nowak, Derralynn A Hughes, Mark Thomas, Raphael Schiffmann, Ales Linhart, David G Warnock, Sandro Feriozzi, Patricio Aguiar, Patrick B Deegan, Fatih Ezgu, Andrea Frustaci, Olivier Lidove, Jean-Claude Lubanda, Kathleen Nicholls, Dau-Ming Niu, Uma Ramaswami, Ricardo Reisin, Paula Rozenfeld, Einar Svarstad, Roser Torra, Bojan Vujkovac, Michael L West, Jack Johnson, Mark J Rolfe
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Objectives The PRoposing Early Disease Indicators for Clinical Tracking in Fabry Disease (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators of disease progression that may justify FD-specific treatmen
Externí odkaz:
https://doaj.org/article/d715f78e37c54b91a11df4c1b094fbaf
Autor:
David Micarelli, Teresa Valentina Ranalli, Anna Rita Taddei, Angela Solazzo, Francesca Moccia, Sandro Feriozzi
Publikováno v:
Journal of Nephropathology, Vol 9, Iss 3, Pp e30-e30 (2020)
Rapidly progressive glomerulonephritis (RPGN) is a clinical syndrome manifested by progressive loss of renal function in a short period. At renal biopsy, it is characterized by crescent formation. RPGN may be associated with the presence of circulati
Externí odkaz:
https://doaj.org/article/b85081d0883b4905ad8a61e6a680709a
Autor:
Sandro Feriozzi, Mario Mangeri
Publikováno v:
Giornale di Clinica Nefrologia e Dialisi, Vol 31, Iss 2 (2019)
The markers of renal involvement in Anderson-Fabry disease are defects of urine concentration, presence of cells with lipid cytoplasmatic inclusions (mulberry bodies) and podocyturia. The loss of urine concentrating capacity is not easy to detect and
Externí odkaz:
https://doaj.org/article/7e2fed0717e8439cab29d1cc8a5306e8
Autor:
Simeone, Andrulli, Michele, Rossini, Giuseppe, Gigliotti, Gaetano, La Manna, Sandro, Feriozzi, Filippo, Aucella, Antonio, Granata, Elisabetta, Moggia, Domenico, Santoro, Lucio, Manenti, Barbara, Infante, Angelo, Ferrantelli, Rosario, Cianci, Mario, Giordano, Domenico, Giannese, Giuseppe, Seminara, Marina, Di Luca, Mario, Bonomini, Leonardo, Spatola, Francesca, Bruno, Olga, Baraldi, David, Micarelli, Matteo, Piemontese, Giulio, Distefano, Francesca, Mattozzi, Paola, De Giovanni, Davide, Penna, Maurizio, Garozzo, Luigi, Vernaglione, Cataldo, Abaterusso, Fulvia, Zanchelli, Rachele, Brugnano, Enrica, Gintoli, Laura, Sottini, Marco, Quaglia, Gioacchino Li, Cavoli, Marco, De Fabritiis, Maria Maddalena, Conte, Massimo, Manes, Yuri, Battaglia, Francesco, Fontana, Loreto, Gesualdo
Publikováno v:
Nephrology Dialysis Transplantation. 38:655-663
Background The known risks and benefits of native kidney biopsies are mainly based on the findings of retrospective studies. The aim of this multicentre prospective study was to evaluate the safety of percutaneous renal biopsies and quantify biopsy-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23fa20970d8a2a900816266ae413461
https://doi.org/10.1093/ndt/gfac177
https://doi.org/10.1093/ndt/gfac177